Compare Heron Therapeutics Inc (HRTX) vs MPLX LP (MPLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs MPLX LP — how do they compare? Heron Therapeutics Inc trades at $0.31 (market cap $61.47M), while MPLX LP trades at $59.72 (market cap $60.12B). The key difference: MPLX LP is far larger — about 978× Heron Therapeutics Inc's market cap, and MPLX LP pays a 7.26% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | MPLX | |
|---|---|---|
Market Cap | $61.47M | $60.12B |
Sector | Health | Technology |
52-Week High | $1.49 | $60.51 |
52-Week Low | $0.32 | $47.80 |
Enterprise Value | $168.21M | $85.22B |
Dividend Yield | — | 7.26% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About MPLX LP
MPLX LP is a Master Limited Partnership (MLP) formed by Marathon Petroleum Corporation (MPC). It is a diversified, growth-oriented company primarily engaged in the gathering, processing, and transportation of natural gas and natural gas liquids (NGLs), as well as the transportation, storage, and distribution of crude oil and refined petroleum products. MPLX owns and operates a network of midstream energy infrastructure assets, providing essential services to the energy industry across the United States.
Read more on MPLX →
